The investment will be used to support childhood cancer patients through ongoing research and care through the After Completion of Therapy Clinic and St. Jude Life Study Program, which aims to increase survivorship and help cancer survivors to thrive.
“Thanks to this awe-inspiring, additional $100 million commitment, St. Jude will continue to help children survive and thrive as it continues in its efforts to help save more of the 400,000 children around the world with cancer and other life-threatening diseases each year,” said Richard Shadyac Jr., President and CEO of ALSAC, the fundraising and awareness organization for St. Jude Children’s Research Hospital.
Signet said that it has raised $100 million over the last 25 years to support children with cancer and other life-threatening diseases, in addition to the $100 million commitment to St. Jude Children’s.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
